InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: BioChica post# 28644

Tuesday, 06/03/2014 3:25:17 PM

Tuesday, June 03, 2014 3:25:17 PM

Post# of 425976
Actually BioChica, one of the significant problems here is that AMARIN has been primarily focused on Triglycerides rather than Inflammation.

The truth is that they've been privy to more than three (3) years of education by members of this and other expert boards demonstrating that inflammation is the problem. There have been more than ONE HUNDRED studies, many posted by Zumantu (thank you!), that illustrate how Vascepa works at a metabolic level that includes, but is not limited to, reduction of TGs (these have all been forwarded to Amarin). I wonder when or if ever Amarin could be expected to learn SOMETHING....AND ACT!!!....instead of allowing every other "johnnie-come-lately" to steal the thunder!

It's an outrage and I've probably stayed involved way too long to still remain objective. JZ was a paper tiger, JT is a neanderthal....he sounds like one anyway. Wonderful representation at Jeffries.......again.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News